ETIGILIMAB
UNII FC1ZF28VIT

Substance Identification & Data

This profile provides standardized clinical and technical data for Etigilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FC1ZF28VIT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2044984-83-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FC1ZF28VIT

CAS Registry Number

2044984-83-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ETIGILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C142821

National Cancer Institute reference terminology for clinical and research data.

INN ID

10742

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-04

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Etigilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ETIGILIMAB

Common Names & Synonyms

ETIGILIMAB [INN]

ETIGILIMAB [USAN]

ETIGILIMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TIGIT(T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS)) (HUMANIZED MOUSE MONOCLONAL OMP-313M32 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL OMP-313M32 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS (V-SET AND IMMUNOGLOBULIN DOMAIN-CONTAINING PROTEIN 9)) HUMANIZED MONOCLONAL ANTIBODY .GAMMA.1 HEAVY CHAIN (1-448) (HOMO SAPIENS VH (IGHV4-38-2*01 (89%) (IGHD)-IGHJ4*01 (93%) (9.7.11) (1-118) -HOMO SAPIENS IGHG1*03) (119-448) (221-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV1-33*01 (85%) IGKJ1*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*05 (108'-214')), DIMER (227-227'':230-230'')-BISDISULFIDE)

External Clinical & Regulatory Resources

Previous UNIIFC1URL572C

Next UNIIFC2L8IO3UP